Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -47475.71% is 57% below its 5-year average of -30327.41%, around the middle of its 5-year range (-78810.00%–0.00%).
10.57% above its 12-month average of -53086.62%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -30463.33%.
NET PROFIT MARGIN
-47475.71%
NET PROFIT MARGIN AVG TTM
-53086.62%
NET PROFIT MARGIN AVG 3Y
-33053.31%
NET PROFIT MARGIN AVG 5Y
-30327.41%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+10.57%
CURRENT VS 3Y AVG
-43.63%
CURRENT VS 5Y AVG
-56.54%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.04%
median of 850 covered companies
CURRENT VS SECTOR MEDIAN
-118689175.00%
vs the sector median at left
Sera Prognostics, Inc.
Market Cap
$77.91M
Net Profit Margin
-47475.71%
TTM Avg
-53086.62%
3Y Avg
-33053.31%
5Y Avg
-30327.41%
Market Cap
$77.38M
Net Profit Margin
-130000.00%
TTM Avg
-89627.13%
3Y Avg
-49555.20%
5Y Avg
-36262.68%
Market Cap
$78.65M
Net Profit Margin
-12.91%
TTM Avg
-907.67%
3Y Avg
-691.25%
5Y Avg
-536.96%
Market Cap
$77.08M
Net Profit Margin
-55.03%
TTM Avg
-63.48%
3Y Avg
-81.34%
5Y Avg
-87.39%
Market Cap
$79.09M
Net Profit Margin
-155404.38%
TTM Avg
-155404.38%
3Y Avg
-155404.38%
5Y Avg
-155404.38%
Market Cap
$76.56M
Net Profit Margin
-63.06%
TTM Avg
-90.45%
3Y Avg
-113.67%
5Y Avg
-137.76%
Market Cap
$76.48M
Net Profit Margin
-210.75%
TTM Avg
-289.10%
3Y Avg
-513.23%
5Y Avg
-2388.54%
Market Cap
$75.75M
Net Profit Margin
-9.79%
TTM Avg
-5.93%
3Y Avg
-6.23%
5Y Avg
-32.51%
Market Cap
$80.47M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sera Prognostics, Inc. (SERA) | $77.91M | -47475.71% | -53086.62% | -33053.31% | -30327.41% |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $77.38M | -130000.00% | -89627.13% | -49555.20% | -36262.68% |
| vTv Therapeutics Inc. (VTVT)vs › | $78.65M | -12.91% | -907.67% | -691.25% | -536.96% |
| Pulmonx Corporation (LUNG)vs › | $77.08M | -55.03% | -63.48% | -81.34% | -87.39% |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $79.09M | -155404.38% | -155404.38% | -155404.38% | -155404.38% |
| Outset Medical, Inc. (OM)vs › | $76.56M | -63.06% | -90.45% | -113.67% | -137.76% |
| Hyperfine, Inc. (HYPR)vs › | $76.48M | -210.75% | -289.10% | -513.23% | -2388.54% |
| SkinHealth Systems Inc. (SKIN)vs › | $75.75M | -9.79% | -5.93% | -6.23% | -32.51% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $80.47M | 0.00% | 0.00% | 0.00% | 0.00% |
| Citius Oncology, Inc. (CTOR)vs › | $80.84M | -648.32% | 0.00% | 0.00% | 0.00% |
Operating Margin
-45066.7%
Net Profit Margin
-47475.7%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -30463.33% |
| 2026-03-31 | -59992.86% |
| 2025-12-31 | -78810.00% |
| 2025-09-30 | -48837.50% |
| 2025-06-30 | -47329.41% |
| 2025-03-31 | -21544.74% |
| 2024-12-31 | -35745.83% |
| 2024-09-30 | -27306.90% |
| 2024-06-30 | -34595.83% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | -19329.27% |
| 2023-09-30 | -17166.67% |
| 2023-06-30 | -8570.73% |
| 2023-03-31 | -10565.00% |
| 2022-12-31 | -14993.85% |
| 2022-09-30 | -12312.64% |
| 2022-06-30 | -14769.23% |
| 2022-03-31 | -32126.32% |
| 2021-12-31 | -48015.38% |
| 2021-09-30 | -42865.22% |
| 2021-06-30 | -31535.00% |
| 2021-03-31 | -48915.38% |
| 2020-12-31 | -89583.33% |
| 2020-09-30 | -101440.00% |
| 2020-06-30 | -78416.67% |
| 2020-03-31 | -58700.00% |
